S4 S4: Synthetic route to HCM; preparation of the MG-scaffold
Tert-butyl (6-((2-(4-(4-(bis(4-(dimethylamino)phenyl)methyl)phenoxy) butanamido)ethyl)amino)-5-(3-(1,3-bis(prop-2-yn-1-yloxy)-2-((prop-2-yn-1-yloxy)methyl)propan-2-yl)ureido)-6-oxohexyl)carbamate MG[H]EDALys(BOC) 1 alkyne 4. Boc anhydride (218 mg, 0.1 mmol) was dissolved in dry methylene chloride (5 mL). Dimethylaminopyridine (122 mg, 1mmol) dissolved in dry methylene chloride (5 mL) was added at rt under argon. 1,3-bis(prop-2-yn-1-yloxy)-2-((prop-2-yn-1-yloxy)methyl)propan-2-amine 1 2 (235 mg/1 mmol) was added and the reaction mixture was stirred for 10 minutes. The in-situ generated "tripod-isocyanate 2" was added to a solution of tert-butyl (5-amino-6-((2-(4-(4-(bis(4-(dimethylamino)phenyl) methyl)phenoxy) butanamido)ethyl)amino)-6-oxohexyl)carbamate [MG[H]-EDALys(Boc)] 3 (703 mg, 1mmol) in anhydrous methylene chloride. The reaction mixture was stirred at rt overnight. The reaction mixture was concentrated and separated by column chromatography on silica gel (eluent: chloroform/10%methanol 
S5
dissolved in ethanol and 2 equiv of 1N HCl was added. The reaction mixture was refluxed until the evolution of CO 2 ceased. The reaction mixture was cooled to rt and adjusted to pH 9 by the addition of ammonium hydroxide. The reaction mixture was concentrated to dryness. The residue was taken up in acetonitrile, filtered and dried to give a light green resin. 1 
EDALys(6)alkyne 6. Boc anhydride (114 mg, 0.5 mmol) was dissolved in dry methylene chloride (3 mL). Dimethylaminopyridine (61 mg, 0.5 mmol) dissolved in dry methylene chloride (3 mL) was added at rt under argon. 1,3-bis(prop-2-yn-1-yloxy)-2-((prop-2-yn-1-yloxy)methyl)propan-2-amine 1 (116 mg/ 0.5 mmol) was added and the reaction mixture was stirred for 10 minutes. The in-situ generated "tripod-isocyanate 2" was added to a solution of 5 (432 mg, 0.5 mmol) in anhydrous acetonitrile. The reaction mixture was stirred at rt overnight. The reaction mixture was concentrated and separated by column chromatography on silica gel (eluent: chloroform/10%methanol 
N-(4-((4-((14-(3-(1,3-bis(prop-2-yn-1-yloxy)-2-((prop-2-yn-1-yloxy)methyl)
propan-2-yl)ureido)-8,15,20-trioxo-6,6-bis((prop-2-yn-1-yloxy)methyl)-4-oxa-7,9,16,19-tetraazatricos-1-yn-23-yl)oxy)phenyl)(4-(dimethylamino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)-N-methylmethanaminium chloride (MG-EDA-Lys(6)alkyne) 7. MG[H]EDALys(6)alkyne 6 (112 mg, 0.1mmol) was dissolved in boiling acetonitrile 5 mL). Chloroanil (36 mg, 1.5 equiv) was added and the reaction mixture was refluxed for 1 hr. A silica gel column in chloroform was prepared. The reaction mixture was poured onto the column. The product adhered to the column, while excess chloroanil passed through. The column was washed with one volume of chloroform and the product was eluted with a gradient of chloroform/methanol 0-20 to yield 92 mg, 80% of 7. Cy3-P1-Br 10. 1-Ethyl-3,3-dimethyl-2-(2-(phenylamino)vinyl)-3H-indol-1-ium-5-sulfonate (338 mg / 1mmol) 8 3 and 1-(2-(2-bromoethoxy)ethyl)-2,3,3-trimethyl-3H-indol-1-ium-5-sulfonate (390 mg, 1mmol) 9 were dissolved in dry DMF (3 mL), pyridine (1 mL) and acetic anhydride (1 mL). The reaction mixture was stirred at 50°C for 2 hrs. The reaction mixture was added drop wise to 50 mL of acetone under stirring precipitating the product. The organic layer was decanted. The residue was dissolve in water/10%ethanol and separated by medium pressure chromatography (Buchi Sepacore System) on a RP-18 column, eluent: water/10-30% ethanol. The product fractions were collected and concentrated to yield 517 mg (70 %) of red crystals. 1 Potassium 1-(2-(2-azidoethoxy)ethyl)1-ethyl-3,3-dimethyl-5-sulfonatoindolin-2-ylidene)prop-1-en-1-yl)-3,3-dimethyl-3H-indol-1-ium-5-sulfonate Cy3-P1-azide 11.Cy3-P1-Br 10 (790 mg, 1mmol) was dissolved in dry DMF (5mL). Sodium azide (130 mg, 2 equiv) were added and the reaction mixture was stirred overnight. The reaction mixture was precipitated by adding drop wise to 50 mL of acetone. The precipitated dye was taken up in water/10 % ethanol. 1M sulfuric acid (2 mL) was added and the reaction mixture was purified by medium pressure chromatography (Buchi Sepacore System) on a RP-18 column, eluent: water/10-30% ethanol. The product fractions were collected and concentrated. The residue was taken up in a minimum amount of methanol drop wise added to a solution of 1M potassium acetate in isopropanol. The potassium salt of Cy3-P1-azide precipitated from the reaction mixture and was collected and dried to yield 500mg (75%) of red crystals. MG-EDA-Lys(6)Cy3-P1 HCM 12. MG-EDA-Lys(6)alkyne 7 (12 mg/0.01 mmol) and Cy311-P1-azide 11 (100 mg/ 0.025 mmol) were dissolved in anhydrous DMSO (20 mL) at 50 C°. Copper(I)bromide (45 mg/0.03 mmol) and PMDTE (1ml) added. The reaction mixture was stirred for 1 hr. After cooling to rt the reaction mixture was precipitated into 200 ml of ethyl acetate. The organic phase was decanted and the residue dissolved in diluted sodium bicarbonate (2 ml). The reaction mixture was separated by medium pressure chromatography (Buchi Sepacore System) on a RP-18 column, eluent: water/0-15% ethanol. The product fractions were further purified by size exclusion chromatography on a P4-Biogel (eluent: water) to separate small amounts of Cy3-P1-azide starting material from the product. Yield: 20 mg (40%) of HCM 12 S8: Numbering of HCM 12 for NMR assignments. 
